RadNet Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Los beneficios de RadNet han disminuido a una tasa media anual de -8.8%, mientras que en la industria Healthcare los beneficios crecieron en un 5.3% anualmente. Los ingresos han ido creciendo a una tasa media de 10.1% al año.
Información clave
-8.8%
Tasa de crecimiento de los beneficios
-11.6%
Tasa de crecimiento del BPA
| Crecimiento de la industria Healthcare | 8.5% |
| Tasa de crecimiento de los ingresos | 10.1% |
| Rentabilidad financiera | 2.7% |
| Margen neto | -0.2% |
| Última actualización de beneficios | 30 Sep 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
There's Reason For Concern Over RadNet, Inc.'s (NASDAQ:RDNT) Massive 26% Price Jump
Nov 12
Here's What To Make Of RadNet's (NASDAQ:RDNT) Decelerating Rates Of Return
Oct 15RadNet: Secular Tailwinds Underpinned By AI Monetization Prospects
Oct 02Unpleasant Surprises Could Be In Store For RadNet, Inc.'s (NASDAQ:RDNT) Shares
Sep 22RadNet: Growth In Operating Earnings Off Very Little Incremental Capital
Aug 24RadNet (NASDAQ:RDNT) Seems To Use Debt Quite Sensibly
Jul 22Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled
Jun 05RadNet: Qualified Growth Route, Still Undervalued
Jun 05Is There Now An Opportunity In RadNet, Inc. (NASDAQ:RDNT)?
May 10Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?
Apr 08RadNet, Inc.'s (NASDAQ:RDNT) 26% Price Boost Is Out Of Tune With Revenues
Mar 06Why RadNet, Inc. (NASDAQ:RDNT) Could Be Worth Watching
Feb 08RadNet, Inc. Stock Price Is More Vigorous Than Its Valuation
Jan 28Getting In Cheap On RadNet, Inc. (NASDAQ:RDNT) Might Be Difficult
Dec 28We Think RadNet (NASDAQ:RDNT) Can Stay On Top Of Its Debt
Dec 04RadNet (NASDAQ:RDNT) Might Be Having Difficulty Using Its Capital Effectively
Aug 27RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt
Aug 09We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt
Mar 30RadNet (NASDAQ:RDNT) Will Want To Turn Around Its Return Trends
Feb 19RadNet (NASDAQ:RDNT) Has A Somewhat Strained Balance Sheet
Dec 12An Intrinsic Calculation For RadNet, Inc. (NASDAQ:RDNT) Suggests It's 41% Undervalued
Nov 26RadNet JV acquires Montclair Radiology's outpatient radiology assets
Oct 11Some Investors May Be Worried About RadNet's (NASDAQ:RDNT) Returns On Capital
Oct 10RadNet Presents With The Idiosyncratic Risk Premia To Deliver Risk-Adjusted Alpha
Aug 28Here's Why RadNet (NASDAQ:RDNT) Has A Meaningful Debt Burden
Aug 12RadNet Non-GAAP EPS of $0.15 beats by $0.06, revenue of $354.1M beats by $5.16M;reaffirms FY guidance
Aug 09RadNet (NASDAQ:RDNT) Is Reinvesting At Lower Rates Of Return
Jul 01Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?
Jun 17Is RadNet (NASDAQ:RDNT) A Risky Investment?
May 11Estimating The Intrinsic Value Of RadNet, Inc. (NASDAQ:RDNT)
Apr 06Desglose de ingresos y gastos
Cómo gana y gasta dinero RadNet. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Sep 24 | 1,773 | -4 | 175 | 0 |
| 30 Jun 24 | 1,714 | 10 | 142 | 0 |
| 31 Mar 24 | 1,658 | 21 | 142 | 0 |
| 31 Dec 23 | 1,617 | 3 | 142 | 0 |
| 30 Sep 23 | 1,580 | 4 | 140 | 0 |
| 30 Jun 23 | 1,528 | -13 | 142 | 0 |
| 31 Mar 23 | 1,479 | -13 | 173 | 0 |
| 31 Dec 22 | 1,430 | 11 | 144 | 0 |
| 30 Sep 22 | 1,382 | 8 | 92 | 0 |
| 30 Jun 22 | 1,365 | 23 | 61 | 0 |
| 31 Mar 22 | 1,344 | 18 | 0 | 0 |
| 31 Dec 21 | 1,324 | 25 | 0 | 0 |
| 30 Sep 21 | 1,297 | 35 | 108 | 0 |
| 30 Jun 21 | 1,256 | 24 | 55 | 0 |
| 31 Mar 21 | 1,138 | 11 | 81 | 0 |
| 31 Dec 20 | 1,098 | -15 | 0 | 0 |
| 30 Sep 20 | 1,090 | -10 | 106 | 0 |
| 30 Jun 20 | 1,091 | -13 | 108 | 0 |
| 31 Mar 20 | 1,164 | 2 | 133 | 0 |
| 31 Dec 19 | 1,154 | 15 | 0 | 0 |
| 30 Sep 19 | 1,111 | 33 | 24 | 0 |
| 30 Jun 19 | 1,060 | 35 | 99 | 0 |
| 31 Mar 19 | 1,015 | 36 | 90 | 0 |
| 31 Dec 18 | 975 | 32 | 0 | 0 |
| 30 Sep 18 | 953 | -4 | 85 | 0 |
| 30 Jun 18 | 939 | -6 | 83 | 0 |
| 31 Mar 18 | 925 | -6 | 59 | 0 |
| 31 Dec 17 | 922 | 0 | 0 | 0 |
| 30 Sep 17 | 912 | 11 | 77 | 0 |
| 30 Jun 17 | 909 | 9 | 74 | 0 |
| 31 Mar 17 | 897 | 7 | 75 | 0 |
| 31 Dec 16 | 885 | 7 | 74 | 0 |
| 30 Sep 16 | 875 | 5 | 75 | 0 |
| 30 Jun 16 | 859 | 11 | 76 | 0 |
| 31 Mar 16 | 845 | 11 | 74 | 0 |
| 31 Dec 15 | 810 | 8 | 72 | 0 |
| 30 Sep 15 | 779 | 11 | 70 | 0 |
| 30 Jun 15 | 755 | 7 | 68 | 0 |
| 31 Mar 15 | 730 | 9 | 66 | 0 |
| 31 Dec 14 | 718 | 1 | 64 | 0 |
| 30 Sep 14 | 710 | -2 | 63 | 0 |
| 30 Jun 14 | 701 | -7 | 63 | 0 |
| 31 Mar 14 | 699 | -9 | 64 | 0 |
| 31 Dec 13 | 703 | 2 | 65 | 0 |
Ingresos de calidad: RDNT actualmente no es rentable.
Margen de beneficios creciente: RDNT actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: RDNT no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 8.8% al año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de RDNT en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: RDNT no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Healthcare (10.3%).
Rentabilidad financiera
Alta ROE: RDNT tiene una rentabilidad financiera negativa (2.73%), ya que actualmente no es rentable.